Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Jen Liu

Showing results (281-290 of 400) with videos related to

Pageof 40
Sort By:
Alimentary Pharmacology & Therapeutics|January 19, 2021
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral loadTai-Chung Tseng, Chun-Jen Liu, Wan-Ting Yang, et al.
Hepatology (Baltimore, Md.)|March 20, 2025
Higher level of Hepatitis B Surface antigen associated with delayed development of hepatocellular carcinoma in immune-tolerant patientsTai-Chung Tseng, Tetsuya Hosaka, Mei-Hung Pan, et al.
Hepatology International|November 11, 2010
Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infectionChing-Sheng Hsu, Chia-Chi Wang, Pin-Chao Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 12, 2011
Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patientsChen-Hua Liu, Cheng-Chao Liang, Kai-Wen Huang, et al.
Hepatology (Baltimore, Md.)|March 25, 2006
Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized studyChun-Jen Liu, Ming-Yang Lai, You-Chen Chao, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 5, 2023
Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resectionTung-Hung Su, Shang-Chin Huang, Chi-Ling Chen, et al.
Scientific Reports|December 1, 2015
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort StudyChen-Hua Liu, Wang-Hui Sheng, Hsin-Yun Sun, et al.
Plos One|November 27, 2014
Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinomaHsiang-Yun Cheng, Pei-Jen Kang, Ya-Hui Chuang, et al.
Gut|June 20, 2025
Hepatitis B surface antigen level identifies patients with inactive chronic hepatitis B from Asia with HCC risk below surveillance thresholdTai-Chung Tseng, Shang-Chin Huang, Mei-Hung Pan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 23, 2023
Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and SeroconversionShang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, et al.
Pageof 40

Showing results (281-290 of 400) with videos related to

Sort By:
Pageof 40
Alimentary Pharmacology & Therapeutics|January 19, 2021
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral loadTai-Chung Tseng, Chun-Jen Liu, Wan-Ting Yang, et al.
Hepatology (Baltimore, Md.)|March 20, 2025
Higher level of Hepatitis B Surface antigen associated with delayed development of hepatocellular carcinoma in immune-tolerant patientsTai-Chung Tseng, Tetsuya Hosaka, Mei-Hung Pan, et al.
Hepatology International|November 11, 2010
Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infectionChing-Sheng Hsu, Chia-Chi Wang, Pin-Chao Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 12, 2011
Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patientsChen-Hua Liu, Cheng-Chao Liang, Kai-Wen Huang, et al.
Hepatology (Baltimore, Md.)|March 25, 2006
Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized studyChun-Jen Liu, Ming-Yang Lai, You-Chen Chao, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 5, 2023
Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resectionTung-Hung Su, Shang-Chin Huang, Chi-Ling Chen, et al.
Scientific Reports|December 1, 2015
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort StudyChen-Hua Liu, Wang-Hui Sheng, Hsin-Yun Sun, et al.
Plos One|November 27, 2014
Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinomaHsiang-Yun Cheng, Pei-Jen Kang, Ya-Hui Chuang, et al.
Gut|June 20, 2025
Hepatitis B surface antigen level identifies patients with inactive chronic hepatitis B from Asia with HCC risk below surveillance thresholdTai-Chung Tseng, Shang-Chin Huang, Mei-Hung Pan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 23, 2023
Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and SeroconversionShang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, et al.
Pageof 40